Search

Because currently available blood warmers are inadequate for infants and children requiring massive transfusion, the performance of a new high-efficiency pediatric blood warmer (System 250TM, LEVEL 1 Technologies Inc., Marshfield, Massachusetts) was evaluated and compared with a commonly used conventional blood warmer (Model DW1000A, American Pharmaseal, Valencia, California). Cold (5-6 degrees C), diluted red blood cells (RBC) (Hct = 30%) were infused through the warmers over a series of flow rates, and the resulting temperatures of the infusate were measured. The flow rates of diluted packed RBC were also measured over a series of infusion pressures. At a flow rate of 225 ml/min, the output temperature of the System 250TM was 33.6 degrees C compared with 24.6 degrees C (P less than 0.05) for the conventional warmer. Above a flow rate of 250 ml/min, however, the water bath of the System 250TM cooled significantly, resulting in a deterioration of performance and an output temperature of only 24.2 degrees C at a flow rate of 400 ml/min. With a 16-G catheter attached, the flow rate at a pressure of 300 mmHg was 223 ml/min through the System 250TM compared with 160 ml/min (P less than 0.05) for the conventional warmer. The System 250TM produced higher output temperatures and a lower resistance to flow compared with the conventional warmer, but flow rates of cold blood through the System 250TM should be restricted to 250 ml/min or less to ensure adequate warming.

Pentobarbitone, 20 mg X kg-1 IV followed by infusion of 25 mg X kg-1 X hr-1, produced a progressive decrease in mean arterial pressure in dogs from 113 +/- 17 mmHg (SD) after one hour of infusion to 82 +/- 21 mmHg after 3.5 hours and to 49 +/- 22 mmHg after 5.5 hours. EEG silence occurred at 3.6 +/- 0.6 hours. In dogs similarly treated with pentobarbitone, a two hour infusion of dopamine 5 micrograms X kg-1 X min-1 beginning at the time of EEG silence prevented the further decrease in pressure and restored pressure to 87 +/- 18 mmHg. The mechanism for this effect of dopamine was an increase in cardiac output as systemic vascular resistance was unaffected by dopamine. The cardiac output increase was mainly the result of an increase in stroke volume as heart rate increased only slightly. Since reduced stroke volume was the main reason why pentobarbitone lowered blood pressure, the effect of dopamine on stroke volume and thus on blood pressure makes it an appropriate antagonist to the cardiovascular effects of toxic doses of pentobarbitone.

The effect of age on the arrhythmogenicity of epinephrine during halothane anaesthesia was studied in pigs of two different age groups. At a stable alveolar concentration of 0.84 volumes per cent halothane, ventricular arrhythmias could not be elicited in one- to three-day-old pigs by a 100 micrograms X kg-1 infusion of epinephrine. PVCs were produced in 50- to 55-day-old pigs at a mean epinephrine dose of 9.55 micrograms X kg-1. Heart rate, systolic blood pressure, and rate-pressure product were significantly higher before and during the epinephrine infusion in the 50- to 55-day-old pigs. It is concluded that there is an age dependent effect upon epinephrine induced arrhythmias during halothane anaesthesia in pigs.

A retrospective analysis of infants with necrotizing enterocolitis was done to evaluate the effects of preoperative abnormalities upon anaesthesia and mortality. Mortality was significantly increased in infants weighing less than 1500 grams (p less than .001). Sixty-nine per cent of the infants had hyaline membrane disease and 35 per cent had platelet counts less than 50 X 10(9) cells/litre (50,000/mm3). Perioperative problems include peritonitis, sepsis, hypovolaemia, acidosis, and prematurity. Other ramifications of prematurity and anaesthesia are discussed.